Comparing the Extent to Which AQ280 is Made Available in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a Phase 1, investigator- and participant-blinded, placebo-controlled, randomized, crossover study to compare bioavailability of AQ280 following single oral doses of a capsule formulation versus a tablet for oral suspension formulation in healthy participants.
Epistemonikos ID: fb3907160f238ffed217baa45613c635bfb79846
First added on: Jul 31, 2025